Advertisement

Prednisone Tablets

[17 July 2014]

Products Affected - Description

Prednisone Tablets, Cadista
1 mg tablets, 100 count (NDC 59746-0171-06)
1 mg tablets, 1000 count (NDC 59746-0171-10)
5 mg tablets, 100 count (NDC 59746-0172-06)
5 mg tablets, 1000 count (NDC 59746-0172-10)
10 mg tablets, 1000 count (NDC 59746-0173-10)
10 mg tablets, 100 count (NDC 59746-0173-06)
20 mg tablets, 100 count (NDC 59746-0175-06)
20 mg tablets, 500 count (NDC 59746-0175-09)
 
Prednisone Tablets, West-Ward
2.5 mg tablets, 100 count (NDC 00143-1425-01) - discontinued
20 mg tablets, 100 count (NDC 00143-1477-01) - discontinued
20 mg tablets, 500 count (NDC 00143-1477-05) - discontinued
20 mg tablets, 1000 count (NDC 00143-1477-10) - discontinued
5 mg tablets, 100 count (NDC 00143-1475-01)
5 mg tablets, 1000 count (NDC 00143-1475-10)
10 mg tablets, 100 count (NDC 00143-1473-01)

Reason for the Shortage

  • Cadista states the shortage is due to a raw materials shortage.
  • Perrigo discontinued prednisone tablets in 2013.
  • Roxane and Watson could not provide a reason for the shortage.
  • Qualitest discontinued prednisone 20 mg tablets in August 2013.
  • West-Ward states the reason for the shortage is manufacturing delays.

Available Products

Prednisone Tablets, Roxane
1 mg tablets, 100 count (NDC 00054-4741-25)
1 mg tablets, 1000 count (NDC 00054-4741-31)
1 mg tablets, 100 count unit dose (NDC 00054-8739-25)
2.5 mg tablets, 100 count (NDC 00054-4742-25)
2.5 mg tablets, 100 count unit dose (NDC 00054-8740-25)
5 mg tablets, 1000 count (NDC 00054-4728-31)
5 mg tablets, 100 count (NDC 00054-4728-25)
5 mg tablets, 100 count unit dose (NDC 00054-8724-25)
10 mg tablets, 100 count (NDC 00054-0017-25)
10 mg tablets, 500 count (NDC 00054-0017-29)
10 mg tablets, 100 count unit dose (NDC 00054-0017-20)
20 mg tablets, 100 count (NDC 00054-0018-25)
20 mg tablets, 500 count (NDC 00054-0018-29)
20 mg tablets, 100 count unit dose (NDC 00054-0018-20)
50 mg tablets, 100 count (NDC 00054-0019-25)
50 mg tablets, 100 count unit dose (NDC 00054-0019-20)

Prednisone Tablets, Qualitest
1 mg tablets, 100 count (NDC 00603-5335-21)
1 mg tablets, 1000 count (NDC 00603-5335-32)
2.5 mg tablets, 100 count (NDC 00603-5336-21
5 mg tablets, 21 count (NDC 00603-5337-15)
5 mg tablets, 48 count (NDC 00603-5337-31)
5 mg tablets, 100 count (NDC 00603-5337-21)
5 mg tablets, 1000 count (NDC 00603-5337-32)
10 mg tablets, 21 count (NDC 00603-5338-15)
10 mg tablets, 48 count (NDC 00603-5338-31)
10 mg tablets, 100 count (NDC 00603-5338-21)
10 mg tablets, 1000 count (NDC 00603-5338-32)
 
Prednisone Tablets, Watson
5 mg tablets, 100 count (NDC 00591-5052-01)
5 mg tablets, 1000 count (NDC 00591-5052-10)
10 mg tablets, 100 count (NDC 00591-5442-01)
10 mg tablets, 500 count (NDC 00591-5442-05)
10 mg tablets, 1000 count (NDC 00591-5442-10)
20 mg tablets, 100 count (NDC 00591-5443-01)
20 mg tablets, 500 count (NDC 00591-5443-05)
20 mg tablets, 1000 count (NDC 00591-5443-10)

Prednisone Tablets, West-Ward
5 mg tablets, 100 count (NDC 00143-9740-01)
5 mg tablets, 1000 count (NDC 00143-9740-10)
10 mg tablets, 100 count (NDC 00143-9739-01)
10 mg tablets, 1000 count (NDC 00143-9739-10)
20 mg tablets, 100 count (NDC 00143-9738-01)
20 mg tablets, 500 count (NDC 00143-9738-05)
20 mg tablets, 1000 count (NDC 00143-9738-10)

Estimated Resupply Dates

  • Cadista has all presentations of prednisone tablets available in limited quantities.
  • West-Ward has prednisone tablets 5 mg 100 count (NDC 00143-1475-01), 5 mg 1000 count (NDC 00143-1475-10), and 10 mg 100 count (NDC 00143-1473-01) presentations on back order and the company cannot estimate a release date.

Related Shortages

Updated

July 17, 2014; May 30, 2014; May 15, 2014; April 3, 2014; March 14, 2014; February 5, 2014; January 22, 2014; January 3, 2014; November 27, 2013; October 23, 2013; October 9, 2013; September 26, 2013; August 29, 2013; July 16, 2013; May 1, 2013; April 5, 2013; March 15, 2013; February 7, 2013; January 3, 2013; December 7, 2012; November 16, 2012; November 5, 2012; October 16, 2012; September 26, 2012; September 7, 2012; August 7, 2012; August 3, 2012; July 10, 2012; June 14, 2012. University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement